In short. Combination injectable treatment plans several injectables together so that each one addresses a different layer of facial ageing. The distinction that matters is sequence rather than stacking: muscle activity is settled first, structure restored second, and skin quality built third, with honest intervals between stages. It is a staged programme, not a single appointment.

Key points

  • Each modality acts on a different layer, so effects multiply rather than simply add.
  • Muscle first, structure second, skin third, with intervals between stages.
  • Relaxing overactive muscle first makes the same filler look smoother and last longer.
  • A biostimulator improves the skin envelope, so structural filler needs less volume.
  • It suits multi-layer ageing; a single isolated concern needs only one modality.

Why does layering beat a single treatment?

Facial ageing happens in every layer at once: muscles crease the skin, fat pads shrink and descend, bone resorbs, and skin thins. No single injectable treats all of that, which is why the strongest modern results come from a plan rather than a product.

Each modality works on a different mechanism, so effects multiply rather than merely add. Filler placed on a face where overactive muscles keep folding the skin lasts worse and looks strained; relax the muscle first and the same filler looks smoother and lasts longer. A biostimulator improves the skin envelope so that structural filler needs less volume. Threads reposition tissue that filler alone would have to overfill. Treating layers in concert also means smaller amounts of each product, which keeps results natural.

Which layer does each modality treat?

Modality Layer it treats What it does Place in the programme
Muscle-relaxing injectable Muscle activity Settles overactive muscles that keep folding the skin Stage one; full effect reviewed at two weeks; maintenance every three to six months
Dissolvable gel filler Structure and volume Restores volume and support once muscle activity is balanced Stage two; two weeks for swelling to settle; reviewed every six to eighteen months
Biostimulators (PLLA or PCL) Skin envelope and collagen Improves the skin envelope so structural filler needs less volume Stage three; a course of sessions over the following months
Threads Tissue position Repositions tissue that filler alone would have to overfill When indicated, before or instead of large filler volumes in the same area, with its own settling period
Skin-quality treatments Skin surface and quality Improve skin quality alongside the other layers Stage three, as a course over the following months

Assessment: mapping the face in layers

Combination planning starts with a full-face assessment in layers: dynamic lines at rest and in animation, volume deficits by region, skin quality and laxity, and the patient's priorities and budget. We photograph, map the treatment areas, and agree a staged plan. A medical consultation always comes first; combination treatment is a programme, not a single appointment.

What order should combination treatment follow?

Order matters. A typical sequence:

  • Stage one: a muscle-relaxing injectable to settle overactive muscles, reviewed at two weeks when its full effect is visible.
  • Stage two: structural filler to restore volume and support, placed once muscle activity is balanced, with two weeks for swelling to settle.
  • Stage three: biostimulators or skin-quality treatments across a course of sessions over the following months.
  • Threads, when indicated, are usually placed before or instead of large filler volumes in the same area, with their own settling period.

Spacing treatments lets each result declare itself before the next layer is added, and avoids confusing normal post-treatment swelling with a problem.

Who does it suit, and who needs only one treatment?

Combination treatment suits patients with multi-layer ageing concerns, most people over forty, and anyone whose single-treatment results have plateaued. It is not a licence to treat everything at once: younger patients with one isolated concern often need only one modality, and we say so. Contraindications such as pregnancy, active infection, or certain medical conditions apply to the whole programme and are screened at consultation.

Timeline, recovery and maintenance

A full combination programme typically unfolds over three to six months, with each stage followed by a short recovery: a day or two of swelling or bruising for filler and threads, several days of marks for skin treatments, none for a muscle-relaxing injectable. The payoff is cumulative, and the face looks progressively fresher without any single obvious intervention.

Once the programme is built, maintenance is simpler than construction: a muscle-relaxing injectable every three to six months, filler reviews every six to eighteen months, and periodic skin-quality sessions. We photograph at every visit so decisions are based on evidence, not memory.

Safety when layering, and when to seek review

Layering treatments is safe when planned, but it concentrates risk management. We track total filler volumes over time to avoid overfilling, respect intervals so inflammation from one treatment has settled before the next, and keep every product's placement on record.

Vascular occlusion remains the key filler risk; the team uses careful technique, keeps hyaluronidase immediately available, and follows a written emergency protocol. Threads and biostimulators add their own considerations, such as temporary dimpling, nodules, or prolonged swelling, which we discuss before each stage.

Arrange a medical review if:

  • Severe pain, skin blanching, or a dusky net-like pattern follows any filler session.
  • Swelling, redness, or lumps persist or worsen beyond two weeks after any stage.
  • You develop an asymmetric smile, drooping, or difficulty swallowing after a muscle-relaxing injectable.

Sources

Internal links

Frequently asked questions

Why do combined treatments work better than single ones?

Each modality works on a different mechanism, so their effects multiply rather than merely add. Filler on a face where overactive muscles keep folding the skin looks strained; relax the muscle first and the same filler looks smoother and lasts longer. Smaller amounts of each product keep results natural.

What order should combination treatment follow?

Muscle first, structure second, skin third. Botulinum toxin settles overactive muscles, then structural filler restores volume and support once muscle activity is balanced, then biostimulators or skin-quality treatments run as a course over the following months, with honest intervals between.

Does everyone over forty need combination treatment?

No. It suits patients with multi-layer aging concerns, and anyone whose single-treatment results have plateaued. It is not a licence to treat everything at once: younger patients with one isolated concern often need only one modality, and that should be said plainly.

Risks & Limitations

  • Vascular occlusion — a time-critical emergency in which filler blocks a blood vessel. It can cause skin loss and, rarely, blindness.
  • Nodules, lumps or granuloma formation, which may need treatment or dissolution.
  • Infection at the injection site.
  • Asymmetry or over-correction; over-treatment is harder to correct than under-treatment.
  • Migration of filler away from the intended area.
  • Temporary brow or eyelid droop after botulinum toxin, which resolves as the effect wears off.
  • Bruising and swelling. All injectable results are temporary and maintenance is required.

When to Seek Care

  • Severe pain out of proportion to the procedure, or skin turning white, grey, mottled or dusky — this is a vascular emergency; seek care immediately.
  • Any change in vision — seek emergency care immediately.
  • Fever, spreading redness, warmth or pus at an injection site.
  • A hard, painful lump that is growing.
  • Drooping eyelid, difficulty swallowing, or difficulty breathing after botulinum toxin.

References & Further Reading

  • American Academy of Dermatology (AAD) — injectable safety information
  • American Society of Plastic Surgeons (ASPS) — injectable guidance
  • U.S. Food and Drug Administration (FDA) — approved filler and neurotoxin products
  • National Medical Products Administration (NMPA, China) — approved product status

Medically reviewed by Ke He, MD (何锞), Deputy Director & Head of Skin & Laser Aesthetics. Last reviewed: 18 September 2026.

This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.